GAL3 Protein Expression is Related to Clinical Features of Prolactin-Secreting Pituitary Microadenoma and Predicts its Recurrence after Surgical Treatment
Background: Previous in vitro study showed that Galectin-3 (Gal-3) protein plays an important role in pituitary tumorigenesis, however, the association of Gal-3 expression with the clinical feature and prognosis of pituitary tumor in a clinical setting remains unknown. Methods: We enrolled 220 patie...
Main Authors: | Dongwei Dai, Ya'nan Li, Qiong Lu, Longyang Yu, Weijie Min, Laixing Wang, Yiqun Cao, Zhijian Yue |
---|---|
Format: | Article |
Language: | English |
Published: |
Cell Physiol Biochem Press GmbH & Co KG
2014-04-01
|
Series: | Cellular Physiology and Biochemistry |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/358673 |
Similar Items
-
Functioning pituitary gonadotroph microadenoma responding to GnRH antagonist therapy: a case report
by: Petra Potrebica, et al.
Published: (2023-01-01) -
Clinical Study and Systematic Review of Pituitary Microadenomas vs. Macroadenomas in Cushing’s Disease: Does Size Matter?
by: Amit Akirov, et al.
Published: (2022-03-01) -
Prognostic factors for surgical treatment of prolactin-secreting pituitary adenomas
by: Oleksandr Voznyak, et al.
Published: (2024-02-01) -
Prolactin-secreting pituitary adenomas: male-specific differences in pathogenesis, clinical presentation and treatment
by: Lukasz Dzialach, et al.
Published: (2024-02-01) -
High Ki-67 expression is associated with prolactin secreting pituitary adenomas
by: Bogdan Bălinişteanu, et al.
Published: (2017-05-01)